Topics

Human medicines European public assessment report (EPAR): Fiasp, insulin aspart, Diabetes Mellitus, Date of authorisation: 09/01/2017, Revision: 3, Status: Authorised

13:48 EDT 10 Jul 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Fiasp, insulin aspart, Diabetes Mellitus, Date of authorisation: 09/01/2017, Revision: 3, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Fiasp, insulin aspart, Diabetes Mellitus, Date of authorisation: 09/01/2017, Revision: 3, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Fiasp, insulin aspart, Diabetes Mellitus, Date of authorisation: 09/01/2017, Revision: 3, Status: Authorised"

Quick Search

Relevant Topics

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...